Cesano Alessandra insider trades
Cesano Alessandra has filed 18 Form 4s with the SEC that we hold, for Puma Biotechnology, INC. (PBYI) (Director), Summit Therapeutics Inc. (SMMT) (Director), Zymeworks Inc. (ZYME) (Director) and EPIX (Chief Medical Officer). Across all of them we count 0 purchases worth $0 and 3 sales worth $699.3K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($567.0K). The largest single trade was a sale of 62,150 shares of Puma Biotechnology, INC. worth $567.0K, dated 2026-09-14. Of 1 sale filed since we began reading the 10b5-1 checkbox, 1 (100%) was marked as made under a 10b5-1 trading plan. The first filing on our record is dated 2022-08-02 and the latest 2026-09-16.
Puma Biotechnology, INC. (PBYI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-06-13 | S, sale reported on Form 4 | 12,150 | $41.3K | 2025-06-17 |
| 2025-07-18 | S, sale reported on Form 4 | 27,000 | $91.0K | 2025-07-22 |
| 2026-09-14 | S, sale reported on Form 4 | 62,150 | $567.0K | 2026-09-16 |
Summit Therapeutics Inc. (SMMT)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Zymeworks Inc. (ZYME)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
EPIX
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1827015) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms